NCT03141840View on ClinicalTrials.gov

Clinical Trial of Topical ABL01 Treatment of Onychomycosis

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

August 14, 2017

Primary Completion Date

February 8, 2019

Study Completion Date

February 8, 2019

Conditions
Onychomycosis of Toenail
Interventions
DEVICE

ABL01

Experimental medical device

DEVICE

Placebo

ABL01 lacking active component

Trial Locations (1)

113 52

Fotcompaniet Stockholm, Stockholm

Sponsors

Lead Sponsor

Abbell AB
All Listed Sponsors
lead

Abbell AB

INDUSTRY

NCT03141840 - Clinical Trial of Topical ABL01 Treatment of Onychomycosis | Biotech Hunter | Biotech Hunter